Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 15, Number 1, February 2024, pages 18-28


Hemodynamic Response to Exercise Training in Heart Failure With Reduced Ejection Fraction Patients

Figures

Figure 1.
Figure 1. Flowchart of the study. CPET: cardiopulmonary exercise testing; HFrEF: heart failure with reduced ejection fraction; ICG: impedance cardiography.
Figure 2.
Figure 2. Radar changes in peak hemodynamic parameters in responders (R) and non-responders (NR). CO: cardiac output; DBP: diastolic blood pressure; HR: heart rate; SBP: systolic blood pressure.
Figure 3.
Figure 3. Receiver operating characteristic curves for discrimination between responder and non-responder HFrEF patients. CO: cardiac output; HFrEF: heart failure with reduced ejection fraction; SVR: systemic vascular resistance; V̇O2oxygen uptake.

Tables

Table 1. Baseline Characteristics of HFrEF Patients According to Their Training Response Status
 
VariableAll patients (n = 76)Non-responders (n = 38) (ΔV̇O2peak ≤ 2.2 mL/min/kg)Responders (n = 38) (ΔV̇O2peak > 2.2 mL/min/kg)
Data are expressed as mean ± SD for parametric data or as n (%) for dichotomous variables. AF: atrial fibrillation; BM: body mass; BMI: body mass index; BNP: brain natriuretic peptide; Coro: coronaropathy; DCM: dilated cardiomyopathy; F: female; HFrEF: heart failure with reduced ejection fraction; ICD: implantable cardioverter-defibrillator; M: male; SD: standard deviation.
Sex ratio (F/M)11/65 (14/86)6/32 (16/84)5/33 (13/77)
Age (years)57 ± 1259 ± 1356 ± 12
Height (cm)173.27 ± 9.28172.03 ± 8.18174.49 ± 10.19
BM (kg)72.93 ± 16.6172.79 ± 13.6473.06 ± 13.26
BMI (kg/m2)24.17 ± 4.5424.54 ± 4.1223.80 ± 4.95
Blood analysis
  Hemoglobin (g/dL)12.79 ± 1.9412.84 ± 1.9612.73 ± 1.92
  Creatinine (µmol/L)101 ± 32.86101 ± 41.32100 ± 24.40
  Median of BNP values (pg/mL)384396372
Cardiovascular risk factors
  DCM26 (34)14 (37)12 (32)
  Coro24 (32)13 (34)11 (29)
  Hypertension17 (22)7 (18)10 (26)
  AF7 (9)5 (13)2 (5)
  ICD17 (22)11 (29)6 (16)
  Type 2 diabetes7 (9)5 (13)2 (5)
Baseline medication
  Bisoprolol58 (76)31 (82)27 (71)
  Ramipril53 (70)26 (68)27 (71)
  Eplerenone51 (67)27 (71)24 (63)
  Entresto15 (20)7 (18)8 (21)
  Furosemide56 (74)29 (76)27 (71)

 

Table 2. Hemodynamic Parameters at Rest and at Peak
 
VariablePrePostP-value
At restAt peakAt restAt peakAt restAt peak
Data are expressed as mean ± SD. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. CO: cardiac output; DBP: diastolic blood pressure; HR: heart rate; SBP: systolic blood pressure; SD: standard deviation; SV: stroke volume; SVR: systemic vascular resistance; V̇E: ventilation; V̇E/V̇O2: minute ventilation/oxygen production; V̇E/V̇CO2: minute ventilation/carbon dioxide production; V̇O2: oxygen uptake.
V̇O2 (mL/min/kg)5.31 ± 1.9913.42 ± 3.535.04 ± 1.6015.72 ± 4.820.3264< 0.0001****
HR (bpm)78.95 ± 14.34108.51 ± 22.5273.60 ± 12.80113.55 ± 24.240.0003***0.0056**
SV (mL)61.56 ± 19.3781.72 ± 25.1065.37 ± 16.9389.29 ± 26.180.0496*0.0157*
CO (L/min)4.93 ± 1.408.80 ± 3.324.76 ± 1.1910.08 ± 3.910.18570.0012**
SBP (mm Hg)97.94 ± 19.39125.19 ± 37.3898.56 ± 18.17134.13 ± 36.190.79890.0690
DBP (mm Hg)64.82 ± 16.5069.42 ± 19.6763.10 ± 11.3174.08 ± 18.780.34140.0474*
E (L/min)15.31 ± 4.7947.29 ± 13.9414.49 ± 4.2054.81 ± 16.640.1917< 0.0001****
E/V̇O241.84 ± 8.7150.73 ± 11.5141.43 ± 9.7550.29 ± 11.780.72770.6618
E/V̇CO249.05 ± 9.3345.30 ± 10.3248.30 ± 10.1143.58 ± 9.280.48930.0319*
SVR (dyn.s/cm5)1,250.18 ± 255.69809.79 ± 280.001,246.38 ± 247.72744.21 ± 271.850.91110.0417*

 

Table 3. Hemodynamic Parameters at Peak for Responders and Non-Responders
 
VariableNon-responders (n = 38) (ΔV̇O2peak/kg ≤ 2.2 mL/min/kg)Responders (n = 38) (ΔV̇O2peak/kg > 2.2 mL/min/kg)P-value
Group × time interactionGroupTimea
Data are expressed as mean ± SD. aOverall time P-value in case of a non-significant group × time interaction. bP-value Δ (post - pre) within group. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. CO: cardiac output; DBP: diastolic blood pressure; HR: heart rate; SBP: systolic blood pressure; SD: standard deviation; SVR: systemic vascular resistance; V̇E: ventilation; V̇E/V̇O2: minute ventilation/oxygen production; V̇E/V̇CO2: minute ventilation/carbon dioxide production; V̇O2oxygen uptake.
SBP (mm Hg)
  Pre128.13 ± 39.53122.33 ± 35.430.11860.94140.0485*
  Post130.18 ± 32.26137.97 ± 39.98
  Δ (post - pre)2.05 ± 39.8615.64 ± 44.43
  P-value Δ (post - pre)b0.94410.0265*
DBP (mm Hg)
  Pre68.66 ± 18.0370.15 ± 21.360.27660.43340.0259*
  Post71.34 ± 16.2676.74 ± 20.82
  Δ (post - pre)2.68 ± 15.726.59 ± 24.00
  P-value Δ (post - pre)0.64950.0392*
E (L/min)
  Pre47.84 ± 12.7646.74 ± 15.15< 0.0001****0.1422< 0.0001****
  Post48.84 ± 14.1760.62 ± 16.99
  Δ (post - pre)1.00 ± 7.6313.87 ± 10.79
  P-value Δ (post - pre)0.7563< 0.0001****
V̇O2 (mL/min/kg)
  Pre13.23 ± 3.6613.59 ± 3.45< 0.0001****0.0017**< 0.0001****
  Post13.05 ± 3.0418.33 ± 4.82
  Δ (post - pre)-0.18 ± 2.284.73 ± 2.62
  P-value Δ (post - pre)0.8457< 0.0001****
HR (bpm)
  Pre108.42 ± 23.37108.59 ± 21.960. 0311*0. 41290. 0040**
  Post109.76 ± 22.96117.23 ± 25.17
  Δ (post - pre)1.34 ± 13.798.64 ± 16.41
  P-value Δ (post - pre)0. 82990. 0010***
E/V̇O2
  Pre52.31 ± 11.4149.18 ± 11.540.61310.18390.7062
  Post52.45 ± 11.5848.20 ± 11.74
  Δ (post - pre)0.13 ± 8.97-0.98 ± 8.45
  P-value Δ (post - pre)0.99470.7817
E/V̇CO2
  Pre46.51 ± 10.1544.11 ± 10.470.37260.18790.0359*
  Post45.52 ± 9.0641.69 ± 9.21
  Δ (post - pre)-0.99 ± 6.52-2.43 ± 7.26
  P-value Δ (post - pre)0.61960.0691
CO (L/min)
  Pre9.02 ± 3.398.59 ± 3.280.0185*0.49630.0011**
  Post9.39 ± 3.7610.75 ± 3.98
  Δ (post - pre)0.37 ± 3.252.16 ± 3.22
  P-value Δ (post - pre)0.73090.0002***
SVR (dyn.s/cm5)
  Pre799.16 ± 278.65820.15 ± 284.550.54070.96370.0515
  Post755.29 ± 254.44733.41 ± 290.73
  Δ (post - pre)-43.87 ± 264.61-86.74 ± 291.99
  P-value Δ (post - pre)0.56150.1363